Inhaltsangabe:
In Real-World Evidence in the Pharmaceutical Landscape, life science industry experts Sunil Dravida and his co-authors have developed the first comprehensive overview of its kind on Real-World Data (RWD) in the pharmaceutical industry. The authors examine the challenges and opportunities in applying real-world data along the pharmaceutical continuum, from clinical development to medical affairs, health economics and outcomes, and marketing. They address the difficulties identifying the suitable data sources, ensuring compliance with privacy, security and regulatory requirements, and the big job of translating data into Real-World Evidence (RWE) to generate meaningful insights that can improve decision making by stakeholders and measurable outcomes that can enhance people's health and well-being. This book is a must-read for those in the pharmaceutical industry involved with RWD, which includes just about every role, as healthcare is now dominated by the need for high-quality data that can enable better decision-making. This book is especially critical for those designing and leading RWD Centers of Excellence in pharmaceutical companies and the service providers supporting the RWD ecosystem.
Sunil Dravida is a Managing Director at NTT Data Services leading the life sciences practice. He has over 30 years of extensive experience in executive management, data and analytics, platform engineering, artificial intelligence, and machine learning. He has worked with many of the world's largest and fastest-growing pharmaceutical and biotech companies and has a relentless passion for improving patient outcomes by leading digital transformation in healthcare. Sunil is an expert in R&D, clinical and Real-World Data and works directly with clients on their RWD/RWE strategies and advanced analytics projects across various groups, including R&D, drug development, medical affairs, HEOR, and market access.
Abhishek Dabral is a leader in the clinical data science space with over 16 years of industry experience in the intersection of statistical programming and data management. He has led teams to implement industry best practices, clinical programming efficiencies, streamlining operations, data standards implementation, governance, data strategy, and innovation. He has extensive experience working across disparate data sources, therapeutic areas, and R&D functions and has worked on many NDA (New Drug Applications) filings, which FDA/EMA/PMDA has successfully approved.
Jugal Sharma, Dr. Qin Ye and Charan Kumar Kuyyamudira have all co-authored this book. Jugal is a data architect with a growing start-up, and he has worked in the healthcare domain for more than a decade. He has worked in the Managed Market, with Real-World Data, and in the regulatory area of healthcare. He is a data geek, and he often shares his knowledge and expertise about healthcare on social media. Dr. Qin Ye is the Global RWE lead for ZS. Qin has been focusing on helping clients realize the value of their RWD investment in R&D to leverage ZS's strategy, data science, and technology capabilities. In his role, Qin leads the development of the RWE team, oversees the development of innovative RWE offerings, and works directly with clients on evidence generation and advanced data sciences programs across clinical, HEOR, medical, and market access functions. Charan Kumar Kuyyamudira is the Director of Operations at Ephicacy, Bangalore, India. Charan has over 16 years of experience in life sciences and has worked for different organizations, including Novartis, IQVIA, and Accenture, in various capacities. He has authored several papers at global conferences, including PharmaSUG, PHUSE, and SCDM. His area of interest includes RWE studies, service and risk management, AI-ML implementation, robotics, green energy, and its implications in operations.
„Über diesen Titel“ kann sich auf eine andere Ausgabe dieses Titels beziehen.
